VARIABILITY OF TOBRAMYCIN PHARMACOKINETICS IN CYSTIC-FIBROSIS

被引：4

作者：

MUNZENBERGER, PJ

COMMISSARIS, RL

MASSOUD, N

HSU, MC

机构：

[1] WAYNE STATE UNIV,CHILDRENS HOSP MICHIGAN,DEPT PHARMACEUT SCI,DETROIT,MI 48202

[2] WAYNE STATE UNIV,CHILDRENS HOSP MICHIGAN,DEPT PEDIAT,DIV PULM MED,DETROIT,MI 48202

来源：

PEDIATRIC INFECTIOUS DISEASE JOURNAL | 1987年 / 6卷 / 08期

关键词：

D O I：

10.1097/00006454-198708000-00009

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：739 / 743

页数：5

共 17 条

[1]

ALEXANDER MR, 1982, AM REV RESPIR DIS, V125, P208

[2]

BAUER LA, 1983, CLIN PHARMACY, V2, P262

[3] IS ANTI-PSEUDOMONAS THERAPY WARRANTED IN ACUTE RESPIRATORY EXACERBATIONS IN CHILDREN WITH CYSTIC-FIBROSIS [J].

BEAUDRY, PH ;

MARKS, MI ;

MCDOUGALL, D ;

DESMOND, K ;

RANGEL, R .

JOURNAL OF PEDIATRICS, 1980, 97 (01) :144-147

[4]

BOSSO JA, 1987, CLIN PHARMACY, V6, P54

[5] AMINOGLYCOSIDE CLEARANCE IN PATIENTS WITH CYSTIC-FIBROSIS [J].

FINKELSTEIN, E ;

HALL, K .

JOURNAL OF PEDIATRICS, 1979, 94 (01) :163-164

[6] CONTROLLED TRIAL OF CEFTAZIDIME VS TICARCILLIN AND TOBRAMYCIN IN THE TREATMENT OF ACUTE RESPIRATORY EXACERBATIONS IN PATIENTS WITH CYSTIC-FIBROSIS [J].

GOLD, R ;

OVERMEYER, A ;

KNIE, B ;

FLEMING, PC ;

LEVISON, H .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1985, 4 (02) :172-177

[7] INDIVIDUALIZATION OF TOBRAMYCIN DOSAGE IN PATIENTS WITH CYSTIC-FIBROSIS [J].

HSU, MC ;

AGUILA, HA ;

SCHMIDT, VL ;

MUNZENBERGER, PJ ;

KAUFFMAN, RE ;

POLGAR, G .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1984, 3 (06) :526-529

[8]

KEARNS GL, 1982, J PEDIATR-US, V100, P312, DOI 10.1016/S0022-3476(82)80663-X

[9] PHARMACOKINETICS OF TOBRAMYCIN IN CYSTIC-FIBROSIS [J].

KELLY, HB ;

MENENDEZ, R ;

FAN, L ;

MURPHY, S .

JOURNAL OF PEDIATRICS, 1982, 100 (02) :318-321

[10] DISPOSITION OF TOBRAMYCIN IN PATIENTS WITH CYSTIC-FIBROSIS - A PROSPECTIVE CONTROLLED-STUDY [J].

LEVY, J ;

SMITH, AL ;

KOUP, JR ;

WILLIAMSWARREN, J ;

RAMSEY, B .

JOURNAL OF PEDIATRICS, 1984, 105 (01) :117-124

← 1 2 →